Shaalan Beg
Science37
Dr. Beg is Vice President of Oncology at Science 37, where he oversees the decentralized clinical trial program for Oncology. He served as Medical Director at the Clinical Research Office of Simmons Comprehensive Cancer and Associate Professor of Hematology and Medical Oncology at UT Southwestern Medical Center in Dallas, Texas where he holds an adjunct faculty position. He is a graduate of ASCO’s Leadership Development Program and has been a member of the Pancreatic Cancer Task Force of the National Cancer Institute (NCI) GI Cancer Steering Committee. Dr. Beg is Associate Editor for ASCO Daily news and is a member of the Bloomberg New Economy International Cancer Coalition.